Mock P A, Shaffer N, Bhadrakom C, Siriwasin W, Chotpitayasunondh T, Chearskul S, Young N L, Roongpisuthipong A, Chinayon P, Kalish M L, Parekh B, Mastro T D
HIV/AIDS Collaboration, Nonthaburi, Thailand.
AIDS. 1999 Feb 25;13(3):407-14. doi: 10.1097/00002030-199902250-00014.
To determine the proportion of HIV-1-infected infants infected in utero and intrapartum, the relationship between transmission risk factors and time of transmission, and the population-attributable fractions for maternal viral load.
Prospective cohort study of 218 formula-fed infants of HIV-1-infected untreated mothers with known infection outcome and a birth HIV-1-positive DNA PCR test result.
Transmission in utero was presumed to have occurred if the birth sample (within 72 h of birth) was HIV-1-positive by PCR; intrapartum transmission was presumed if the birth sample tested negative and a later sample was HIV-1-positive. Two comparisons were carried out for selected risk factors for mother-to-child transmission: infants infected in utero versus all infants with a HIV-1-negative birth PCR test result, and infants infected intrapartum versus uninfected infants.
Of 49 infected infants with an HIV-1 birth PCR result, 12 (24.5%) [95% confidence interval (CI), 14 -38] were presumed to have been infected in utero and 37 (75.5%) were presumed to have been infected intrapartum. The estimated absolute overall transmission rate was 22.5%; this comprised 5.5% (95% CI, 3-9) in utero transmission and 18% (95% CI, 13-24) intrapartum transmission. Intrapartum transmission accounted for 75.5% of infections. High maternal HIV-1 viral load (> median) was a strong risk factor for both in utero [adjusted odds ratio (AOR) 5.8 (95% CI, 1.4-38.8] and intrapartum transmission (AOR, 4.4; 95% CI, 1.9-11.2). Low birth-weight was associated with in utero transmission, whereas low maternal natural killer cell and CD4(+) T-lymphocyte percentages were associated with intrapartum transmission. The population-attributable fraction for intrapartum transmission associated with viral load > 10 000 copies/ml was 69%.
Our results provide further evidence that most perinatal HIV-1 transmission occurs during labor and delivery, and that risk factors may differ according to time of transmission. Interventions to reduce maternal viral load should be effective in reducing both in utero and intrapartum transmission.
确定感染人类免疫缺陷病毒1型(HIV-1)的婴儿在子宫内和分娩期间感染的比例、传播风险因素与传播时间之间的关系,以及母亲病毒载量的人群归因分数。
对218名由感染HIV-1且未经治疗的母亲以配方奶喂养的婴儿进行前瞻性队列研究,这些婴儿已知感染结局且出生时HIV-1 DNA聚合酶链反应(PCR)检测结果为阳性。
如果出生样本(出生后72小时内)经PCR检测HIV-1呈阳性,则推测为子宫内传播;如果出生样本检测为阴性而后来的样本HIV-1呈阳性,则推测为分娩期间传播。针对母婴传播的选定风险因素进行了两项比较:子宫内感染的婴儿与出生时PCR检测HIV-1呈阴性的所有婴儿,以及分娩期间感染的婴儿与未感染的婴儿。
在49名出生时HIV-1 PCR检测结果呈阳性的感染婴儿中,12名(24.5%)[95%置信区间(CI),14 - 38]推测为子宫内感染,37名(75.5%)推测为分娩期间感染。估计的总体绝对传播率为22.5%;其中子宫内传播占5.5%(95% CI,3 - 9),分娩期间传播占18%(95% CI,13 - 24)。分娩期间传播占感染的75.5%。母亲HIV-1病毒载量高(>中位数)是子宫内传播[调整优势比(AOR)5.8(95% CI,1.4 - 38.8)]和分娩期间传播(AOR,4.4;95% CI,1.9 - 11.2)的强风险因素。低出生体重与子宫内传播相关,而母亲自然杀伤细胞和CD4(+) T淋巴细胞百分比低与分娩期间传播相关。与病毒载量>10000拷贝/ml相关的分娩期间传播的人群归因分数为69%。
我们的结果提供了进一步的证据,表明大多数围产期HIV-1传播发生在分娩期间,并且风险因素可能因传播时间而异。降低母亲病毒载量的干预措施应能有效减少子宫内和分娩期间的传播。